Introduction
Breast cancer is the leading cancer among women in the USA and most Western countries, and the incidence rates are approximately 100 per 100 000 population. From 1970 From to 1990 there has been a 117 and 50% increase in breast cancer incidence and mortality respectively in the USA; however, the age\ x=req-\ adjusted increased incidence and mortality are 21 and 3% respectively within this same time-period. These increases have primarily been observed in older postmenopausal women (Sondik 1994 , Ries 1995 ). There are also major geographical differences in breast cancer incidence between Western (high incidence) and Asian (low incidence) countries.
However, several studies have demonstrated that breast cancer incidence increases dramatically in Asian immigrants in the USA, suggesting that differences between these populations are not due to race but to other 'environmental factors' including diet. An important component in the contribution of 'environmental factors' appears to be a woman's overall lifetime exposure to estrogens (Pike et al. 1993 , Hulka et al. 1994 ). The following hormonally related factors increase the risk for breast cancer: late age at menopause, null parity, late age at first birth, early age at menarche and estrogen replacement therapy. Some of these factors involving lifetime estrogen exposure may also be responsible, in part, for differ¬ ences in breast cancer incidence between China and the USA; for example, the average age of menarche is 17 and 12.8 years in the two countries respectively.
It has been difficult to assess the role of diet in breast cancer; for example, the effects of dietary fat intake are equivocal; however, body mass index (obesity) is a risk factor for women over 31. The role of fat and other dietary components in breast cancer is complex and requires further research (Marshall 1993 , Willett & Hunter 1994 . It has also been suggested that mutagenic aromatic amines such as 2-amino-lmethyl-6-phenylimidazo [4,5-£] Soto eí al. 1991 , Krishnan etal. 1993 , White etal. 1993 ,Jobling etal. 1995 (Wetzel et al. 1994 ). Moreover, a recent study in this laboratory using several diag¬ nostic estrogen-responsive assays concluded that atrazine and simazine were not estrogenic (Connor ef al. 1996) and this was also confirmed in the E-screen assay (Soto eí al. 1995) . Davis et al. (1993) also cited a study by Scribner & Mottet (1981) which showed that DDT increased the incidence of mammary tumors in male mice treated with acetamidophenanthrene. However, an earlier study by Silinskas & Okey (1975) (Safe 1994 (Safe 1995a Figure 3 Possible mechanisms of the antiestrogenic effects of TCDD (Safe 1995a (Safe 1995a aThe estrogen/antiestrogen equivalents data for bioflavonoids and organochlorine pesticides utilized relative potency factors (rei. pot. factor) reported by Soto ef al. (1994 Soto ef al. ( , 1995 . The relative antiestrogenic potency factors for TCDD, I3C and PAHs were also derived from studies in breast cancer cells (Chaloupka etal. 1992 , Liu et al. 1994 , Safe 1995a . In vitro studies with TCDD and E2 indicate that these compounds are as equipotent as antiestrogens and estrogens respectively for most responses and therefore one antiestrogen equivalent (using TCDD equivalents) is similar to one estrogen equivalent (using E2 equivalents) (Safe 1995a 
